To provide a concise introduction and download reference for the Biological Diversity Act, 2002, with emphasis on access to biological resources, benefit sharing, biodiversity governance and its relevance to pharmaceutical innovation and research.
Overview #
The Biological Diversity Act, 2002 is India’s principal legislation for conservation of biological diversity, sustainable use of biological resources and fair and equitable sharing of benefits arising from their use. Although titled as a 2002 Act, the statute is Act No. 18 of 2003 and received assent on 5 February 2003.
For drug law, biotechnology, herbal medicine and pharmaceutical research, the Act is important because it regulates access to Indian biological resources and associated knowledge, transfer of research results, and applications for intellectual property rights based on such resources. It also creates institutional mechanisms such as the National Biodiversity Authority, State Biodiversity Boards and Biodiversity Management Committees.
Object of the legislation #
The object of the Act is to give effect to India’s obligations under the United Nations Convention on Biological Diversity and, as reflected in the statutory preamble, to recognise India’s sovereign rights over its biological resources. The Act seeks to balance three connected objectives: conservation of biological diversity, sustainable use of its components, and fair and equitable benefit sharing from the use of biological resources and knowledge.
The Act is particularly relevant where biological resources, genetic material, plant varieties, microorganisms, traditional knowledge or contemporary knowledge systems are used for research, product development, commercial utilisation or intellectual property protection.
Scope and relevance #
The Act extends to the whole of India. Its regulatory scheme covers access to biological resources, transfer of research outcomes, approval for intellectual property applications, benefit-sharing arrangements, biodiversity funds, heritage sites, threatened species, repositories and local-level biodiversity management.
In practical terms, lawyers and researchers should examine this Act whenever a project involves Indian biological material or associated knowledge in areas such as herbal formulations, nutraceuticals, biotechnology, fermentation-based products, natural product discovery, cosmetics, food ingredients, agriculture-linked innovation or pharma R&D. Compliance may be relevant before entering collaborations, transferring research results, filing patent applications or commercialising products derived from Indian biological resources.
Selected important provisions and themes #
- Section 3 regulates biodiversity-related activities by certain persons and requires approval of the National Biodiversity Authority.
- Section 4 deals with transfer of results of research to certain persons without approval of the National Biodiversity Authority.
- Section 6 restricts applications for intellectual property rights based on biological resources without approval of the National Biodiversity Authority.
- Section 7 requires prior intimation to the State Biodiversity Board for accessing biological resources for certain purposes.
- Sections 8 to 18 establish the National Biodiversity Authority and set out its institutional structure, powers and functions.
- Sections 19 to 21 deal with approvals by the National Biodiversity Authority, transfer of research results and determination of fair and equitable benefit sharing.
- Sections 22 to 24 provide for State Biodiversity Boards and their role in restricting activities inconsistent with conservation and sustainable use objectives.
- Sections 36 to 41 cover government duties, biodiversity heritage sites, threatened species, repositories and the constitution of Biodiversity Management Committees.
How to use this Bare Act #
- Use this Bare Act first to identify whether a proposed research, commercial or intellectual property activity involves Indian biological resources or associated knowledge.
- Check whether approval from the National Biodiversity Authority or prior intimation to a State Biodiversity Board may be required before proceeding.
- For pharmaceutical, biotechnology or herbal-product work, review the Act before filing patent applications or transferring research results to foreign collaborators.
- Read the Act together with applicable biodiversity rules, regulations, notifications and benefit-sharing guidelines issued by the competent authorities.
- Where the activity also involves drugs, cosmetics, food products, hazardous substances or environmental compliance, read this Act with the sector-specific legislation.
Related Bare Acts and statutes #
- Environment Protection Act, 1986
- Drugs and Cosmetics Act, 1940 with Rules 1945
- Food Safety and Standards Act, 2006
- Hazardous and Other Wastes (Management and Transboundary Movement) Rules, 2015
This page is intended as a Bare Act reference for legal study and professional research. Users should verify the latest amended text, rules, regulations, notifications and official guidance before relying on the Act for compliance, litigation, intellectual property filing or commercial decisions.
